Kahveci, A. M.; Tahan, V. Daclatasvir Plus Sofosbuvir Regimen Sheds Promising Light on Future Hepatitis C Virus Genotype 3 Therapies. Turkish Journal of Gastroenterology 2016, 27, 89-90.